H.A. Verbrugh

800 total citations
20 papers, 458 citations indexed

About

H.A. Verbrugh is a scholar working on Infectious Diseases, Epidemiology and Applied Microbiology and Biotechnology. According to data from OpenAlex, H.A. Verbrugh has authored 20 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in Applied Microbiology and Biotechnology. Recurrent topics in H.A. Verbrugh's work include Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotic Use and Resistance (5 papers) and Bacterial Identification and Susceptibility Testing (4 papers). H.A. Verbrugh is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotic Use and Resistance (5 papers) and Bacterial Identification and Susceptibility Testing (4 papers). H.A. Verbrugh collaborates with scholars based in Netherlands, United States and Indonesia. H.A. Verbrugh's co-authors include R P Verkooyen, Phillip K. Peterson, W N M Hustinx, P Leguit, Peter J. de Vries, A.J. Mintjes-de Groot, R. Peters, J. Verhoef, J. Verhoef and Inez-Anne Haagen and has published in prestigious journals such as The Lancet, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

H.A. Verbrugh

20 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.A. Verbrugh Netherlands 10 183 165 95 69 64 20 458
A. J. Bint United Kingdom 15 161 0.9× 82 0.5× 138 1.5× 70 1.0× 38 0.6× 44 527
G. A. Richard United States 11 264 1.4× 83 0.5× 77 0.8× 58 0.8× 106 1.7× 20 431
Gaye Usluer Türkiye 15 266 1.5× 124 0.8× 37 0.4× 48 0.7× 42 0.7× 28 567
W R Bowie Canada 14 252 1.4× 66 0.4× 142 1.5× 40 0.6× 43 0.7× 23 576
Jacobo Sabbaj Guatemala 10 159 0.9× 148 0.9× 78 0.8× 46 0.7× 46 0.7× 13 389
Anand P. Panwalker United States 13 257 1.4× 189 1.1× 168 1.8× 69 1.0× 26 0.4× 27 651
S Schönwald Croatia 12 337 1.8× 62 0.4× 74 0.8× 34 0.5× 80 1.3× 25 507
Gisela Otto Sweden 11 312 1.7× 63 0.4× 33 0.3× 98 1.4× 94 1.5× 17 626
A Iravani United States 12 379 2.1× 94 0.6× 124 1.3× 61 0.9× 175 2.7× 35 575
J. Richards United Kingdom 8 135 0.7× 90 0.5× 35 0.4× 61 0.9× 28 0.4× 13 422

Countries citing papers authored by H.A. Verbrugh

Since Specialization
Citations

This map shows the geographic impact of H.A. Verbrugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.A. Verbrugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.A. Verbrugh more than expected).

Fields of papers citing papers by H.A. Verbrugh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.A. Verbrugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.A. Verbrugh. The network helps show where H.A. Verbrugh may publish in the future.

Co-authorship network of co-authors of H.A. Verbrugh

This figure shows the co-authorship network connecting the top 25 collaborators of H.A. Verbrugh. A scholar is included among the top collaborators of H.A. Verbrugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.A. Verbrugh. H.A. Verbrugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anggraini, Dewi, et al.. (2020). Epidemiology study of Acinetobacter spp. isolated from blood culture in Indonesia. International Journal of Infectious Diseases. 101. 62–63. 3 indexed citations
2.
Vos, Martine De, Damian C. Melles∗, Femke Mollema, et al.. (2009). 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands. 4 indexed citations
3.
Goessens, Wil H. F. & H.A. Verbrugh. (2007). [Antibiotic resistance: epidemiological developments and preventive measures].. PubMed. 151(13). 748–52. 5 indexed citations
4.
Nouwen, Jan, Jan Schouten, Susan V. Snijders, et al.. (2006). Staphylococcus aureus carriage patterns and the risk of infections associated with continuous peritoneal dialysis.. 1 indexed citations
5.
Wertheim, Heiman, et al.. (2005). Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.. Oxford University Research Archive (ORA) (University of Oxford). 4 indexed citations
6.
Nouwen, Jan, Hélène Boelens, A.F. vanBelkum, & H.A. Verbrugh. (2004). Human factor in Staphylococcus aureus nasal carriage. 4 indexed citations
7.
Endtz, Hubert P., C. Wim Ang, Nicole van den Braak, et al.. (2000). Evaluation of a New Commercial Immunoassay >for Rapid Detection of Campylobacter jejuni in Stool Samples. European Journal of Clinical Microbiology & Infectious Diseases. 19(10). 794–797. 20 indexed citations
8.
Gyssens, Inge C., Monique Keuter, H.A. Verbrugh, & P.J. van den Broek. (2000). Antimicrobial resistance in Indonesia: prevalence and prevention. 9 indexed citations
9.
Mouton, Johan W., Hubert P. Endtz, Jan G. den Hollander, Nicole van den Braak, & H.A. Verbrugh. (1997). In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis. Journal of Antimicrobial Chemotherapy. 39(suppl 1). 75–80. 23 indexed citations
10.
Verbrugh, H.A., et al.. (1992). Prophylactic ciprofloxacin for catheter-associated urinary-tract infection. The Lancet. 339(8799). 946–951. 72 indexed citations
11.
Hustinx, W N M, A.J. Mintjes-de Groot, R P Verkooyen, & H.A. Verbrugh. (1991). Impact of concurrent antimicrobial therapy on catheter-associated urinary tract infection. Journal of Hospital Infection. 18(1). 45–56. 39 indexed citations
12.
Haagen, Inez-Anne, et al.. (1990). Adherence of Peritonitis-Causing Staphylococci to Human Peritoneal Mesothelial Cell Monolayers. The Journal of Infectious Diseases. 161(2). 266–273. 45 indexed citations
13.
Vries, Peter J. de, R P Verkooyen, P Leguit, & H.A. Verbrugh. (1990). Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections. European Journal of Clinical Microbiology & Infectious Diseases. 9(3). 161–168. 64 indexed citations
14.
Verbrugh, H.A., A.J. Mintjes-de Groot, & R P Verkooyen. (1990). [Registration and prevention of hospital infections in a general hospital].. PubMed. 134(10). 490–5. 3 indexed citations
15.
Meulen, Jan van der, et al.. (1989). The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.. PubMed. 5. 151–3. 8 indexed citations
16.
Verbrugh, H.A., et al.. (1988). Postoperative prophylaxis with norfloxacin in patients requiring bladder catheters. European Journal of Clinical Microbiology & Infectious Diseases. 7(4). 490–494. 20 indexed citations
17.
Verbrugh, H.A., et al.. (1986). Widal-type serology using live antigen for diagnosis ofShigella flexneri dysentery. European Journal of Clinical Microbiology & Infectious Diseases. 5(5). 540–542. 1 indexed citations
18.
Verbrugh, H.A., et al.. (1983). Serology of Staphylococcus aureus Infections Using Multiple Antigens and Serial Serum Samples. The Journal of Infectious Diseases. 148(3). 608–608. 17 indexed citations
19.
Elliott, Greg R., et al.. (1982). Influence of subinhibitory concentrations of penicillin, cephalothin, and clindamycin on Staphylococcus aureus growth in human phagocytic cells. Antimicrobial Agents and Chemotherapy. 22(5). 781–784. 43 indexed citations
20.
Verbrugh, H.A., et al.. (1981). Antibodies to Cell Wall Peptidoglycan of Staphylococcus aureus in Patients with Serious Staphylococcal Infections. The Journal of Infectious Diseases. 144(1). 1–9. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. J. Bint Breakdown of academic impact, for papers by G. A. Richard Breakdown of academic impact, for papers by Gaye Usluer Breakdown of academic impact, for papers by W R Bowie Breakdown of academic impact, for papers by Jacobo Sabbaj Breakdown of academic impact, for papers by Anand P. Panwalker Breakdown of academic impact, for papers by S Schönwald Breakdown of academic impact, for papers by Gisela Otto Breakdown of academic impact, for papers by A Iravani Breakdown of academic impact, for papers by J. Richards
Rankless by CCL
2026